Rosuvastatin in Older Patients with Systolic Heart Failure
Top Cited Papers
- 29 November 2007
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 357 (22), 2248-2261
- https://doi.org/10.1056/nejmoa0706201
Abstract
Patients with systolic heart failure have generally been excluded from statin trials. Acute coronary events are uncommon in this population, and statins have theoretical risks in these patients.Keywords
This publication has 24 references indexed in Scilit:
- The Role of Coenzyme Q10 in Statin-Associated MyopathyJournal of the American College of Cardiology, 2007
- Threats, opportunities, and statins in the modern management of heart failureThe opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.European Heart Journal, 2006
- A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): Study design and baseline characteristicsEuropean Journal of Heart Failure, 2005
- Heart failure and statins—Why do we need a clinical trial?Clinical Research in Cardiology, 2005
- Selenoprotein synthesis and side-effects of statinsThe Lancet, 2004
- The relationship between cholesterol and survival in patients with chronic heart failureJournal of the American College of Cardiology, 2003
- Low serum total cholesterol is associated with marked increase in mortality in advanced heart failureJournal of Cardiac Failure, 2002
- Statins and chronic heart failure: do we need a large-scale outcome trial?Journal of the American College of Cardiology, 2002
- The endotoxin-lipoprotein hypothesisThe Lancet, 2000
- Acute Coronary Findings at Autopsy in Heart Failure Patients With Sudden DeathCirculation, 2000